• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression.

作者信息

Rivano Melania, Cancanelli Luca, Zovi Andrea, Addis Chiara, Mengato Daniele, Chiumente Marco, Messori Andrea

机构信息

Department of Pharmaceutical Sciences, Hospital Pharmacy School, University of Milan, Milan, Italy.

Department of Pharmaceutical Sciences, Hospital Pharmacy School, University of Florence, Florence, Italy.

出版信息

J Chemother. 2020 Sep;32(5):268-271. doi: 10.1080/1120009X.2020.1716492. Epub 2020 Jan 25.

DOI:10.1080/1120009X.2020.1716492
PMID:31984876
Abstract
摘要

相似文献

1
Tyrosine-kinase inhibitor discontinuation in chronic myeloid leukaemia after deep molecular response: a meta-analysis with meta-regression.慢性髓性白血病深度分子反应后酪氨酸激酶抑制剂停药：一项包含Meta回归的Meta分析
J Chemother. 2020 Sep;32(5):268-271. doi: 10.1080/1120009X.2020.1716492. Epub 2020 Jan 25.
2
The spectrum of musculoskeletal symptoms in patients with chronic myeloid leukemia after stopping tyrosine kinase inhibitors.停用酪氨酸激酶抑制剂后慢性髓系白血病患者的肌肉骨骼症状谱
Leuk Res. 2019 Apr;79:1-2. doi: 10.1016/j.leukres.2019.02.001. Epub 2019 Feb 11.
3
Evolving treatment strategies in CML - moving from early and deep molecular responses to TKI discontinuation and treatment-free remission: is there a need for longer-term trial outcomes?慢性粒细胞白血病不断演变的治疗策略——从早期深度分子反应到酪氨酸激酶抑制剂停药和无治疗缓解：是否需要长期试验结果？
Br J Clin Pharmacol. 2018 Aug;84(8):1635-1638. doi: 10.1111/bcp.13637. Epub 2018 Jun 3.
4
E14a2 transcript is associated with a higher rate of treatment-free remission in individuals with chronic myeloid leukemia after stopping tyrosine kinase inhibitor therapy.E14a2转录本与慢性髓性白血病患者在停止酪氨酸激酶抑制剂治疗后更高的无治疗缓解率相关。
Haematologica. 2017 Aug;102(8):e297-e299. doi: 10.3324/haematol.2017.168740. Epub 2017 May 11.
5
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice.酪氨酸激酶抑制剂在慢性髓性白血病治疗中的停药：对当前实践的批判性评价。
Expert Rev Hematol. 2020 Dec;13(12):1311-1318. doi: 10.1080/17474086.2021.1852924. Epub 2020 Dec 1.
6
Treatment-free remission after first-line dasatinib discontinuation in patients with chronic myeloid leukaemia (first-line DADI trial): a single-arm, multicentre, phase 2 trial.慢性髓性白血病患者一线达沙替尼停药后的无治疗缓解（一线DADI试验）：一项单臂、多中心、2期试验
Lancet Haematol. 2020 Mar;7(3):e218-e225. doi: 10.1016/S2352-3026(19)30235-2. Epub 2020 Jan 21.
7
Sudden blastic transformation in treatment-free remission chronic myeloid leukaemia.未经治疗缓解的慢性髓性白血病中的急性原始细胞转化
Br J Haematol. 2019 Nov;187(4):543-545. doi: 10.1111/bjh.16245. Epub 2019 Oct 4.
8
Considerations for Treatment-free Remission in Patients With Chronic Myeloid Leukemia: A Joint Patient-Physician Perspective.慢性髓性白血病患者无需治疗缓解的考量：医患联合视角
Clin Lymphoma Myeloma Leuk. 2018 Jun;18(6):375-379. doi: 10.1016/j.clml.2018.04.005. Epub 2018 Apr 25.
9
Novel tyrosine kinase inhibitors in chronic myelogenous leukemia.慢性粒细胞白血病中的新型酪氨酸激酶抑制剂
Curr Opin Oncol. 2006 Nov;18(6):578-83. doi: 10.1097/01.cco.0000245314.97638.d3.
10
Anxiety and depression associated with tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia.慢性髓性白血病患者酪氨酸激酶抑制剂停药相关的焦虑和抑郁。
Int J Clin Oncol. 2018 Oct;23(5):974-979. doi: 10.1007/s10147-018-1275-6. Epub 2018 Apr 12.